Clinical considerations on antimicrobial resistance potential of complex microbiological samples

Antimicrobial resistance (AMR) is one of our greatest public health challenges. Targeted use of antibiotics (ABs) can reduce the occurrence and spread of AMR and boost the effectiveness of treatment. This requires knowledge of the AB susceptibility of the pathogens involved in the disease. Therapeut...

Full description

Saved in:
Bibliographic Details
Main Authors: Norbert Solymosi, Adrienn Gréta Tóth, Sára Ágnes Nagy, István Csabai, Csongor Feczkó, Tamás Reibling, Tibor Németh
Format: Article
Language:English
Published: PeerJ Inc. 2025-01-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/18802.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832577810409979904
author Norbert Solymosi
Adrienn Gréta Tóth
Sára Ágnes Nagy
István Csabai
Csongor Feczkó
Tamás Reibling
Tibor Németh
author_facet Norbert Solymosi
Adrienn Gréta Tóth
Sára Ágnes Nagy
István Csabai
Csongor Feczkó
Tamás Reibling
Tibor Németh
author_sort Norbert Solymosi
collection DOAJ
description Antimicrobial resistance (AMR) is one of our greatest public health challenges. Targeted use of antibiotics (ABs) can reduce the occurrence and spread of AMR and boost the effectiveness of treatment. This requires knowledge of the AB susceptibility of the pathogens involved in the disease. Therapeutic recommendations based on classical AB susceptibility testing (AST) are based on the analysis of only a fraction of the bacteria present in the disease process. Next and third generation sequencing technologies allow the identification of antimicrobial resistance genes (ARGs) present in a bacterial community. Using this metagenomic approach, we can map the antimicrobial resistance potential (AMRP) of a complex, multi-bacterial microbial sample. To understand the interpretiveness of AMRP, the concordance between phenotypic AMR properties and ARGs was investigated by analyzing data from 574 Escherichia coli strains of five different studies. The overall results show that for 44% of the studied ABs, phenotypically resistant strains are genotypically associated with a 90% probability of resistance, while for 92% of the ABs, the phenotypically susceptible strains are genotypically susceptible with a 90% probability. ARG detection showed a phenotypic prediction with at least 90% confidence in 67% of ABs. The probability of detecting a phenotypically susceptible strain as resistant based on genotype is below 5% for 92% of ABs. While the probability of detecting a phenotypically resistant strain as susceptible based on genotype is below 5% for 44% of ABs. We can assume that these strain-by-strain concordance results are also true for bacteria in complex microbial samples, and conclude that AMRP obtained from metagenomic ARG analysis can help choose efficient ABs. This is illustrated using AMRP by a canine external otitis sample.
format Article
id doaj-art-53af4d679ddb4dfd962babb2c38399ad
institution Kabale University
issn 2167-8359
language English
publishDate 2025-01-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj-art-53af4d679ddb4dfd962babb2c38399ad2025-01-30T15:05:09ZengPeerJ Inc.PeerJ2167-83592025-01-0113e1880210.7717/peerj.18802Clinical considerations on antimicrobial resistance potential of complex microbiological samplesNorbert Solymosi0Adrienn Gréta Tóth1Sára Ágnes Nagy2István Csabai3Csongor Feczkó4Tamás Reibling5Tibor Németh6Centre for Bioinformatics, University of Veterinary Medicine, Budapest, HungaryCentre for Bioinformatics, University of Veterinary Medicine, Budapest, HungaryDepartment of Physics of Complex Systems, Eötvös Loránd University, Budapest, HungaryDepartment of Physics of Complex Systems, Eötvös Loránd University, Budapest, HungaryCentre for Bioinformatics, University of Veterinary Medicine, Budapest, HungaryCentre for Bioinformatics, University of Veterinary Medicine, Budapest, HungaryDepartment and Clinic of Surgery and Ophthalmology, University of Veterinary Medicine, Budapest, HungaryAntimicrobial resistance (AMR) is one of our greatest public health challenges. Targeted use of antibiotics (ABs) can reduce the occurrence and spread of AMR and boost the effectiveness of treatment. This requires knowledge of the AB susceptibility of the pathogens involved in the disease. Therapeutic recommendations based on classical AB susceptibility testing (AST) are based on the analysis of only a fraction of the bacteria present in the disease process. Next and third generation sequencing technologies allow the identification of antimicrobial resistance genes (ARGs) present in a bacterial community. Using this metagenomic approach, we can map the antimicrobial resistance potential (AMRP) of a complex, multi-bacterial microbial sample. To understand the interpretiveness of AMRP, the concordance between phenotypic AMR properties and ARGs was investigated by analyzing data from 574 Escherichia coli strains of five different studies. The overall results show that for 44% of the studied ABs, phenotypically resistant strains are genotypically associated with a 90% probability of resistance, while for 92% of the ABs, the phenotypically susceptible strains are genotypically susceptible with a 90% probability. ARG detection showed a phenotypic prediction with at least 90% confidence in 67% of ABs. The probability of detecting a phenotypically susceptible strain as resistant based on genotype is below 5% for 92% of ABs. While the probability of detecting a phenotypically resistant strain as susceptible based on genotype is below 5% for 44% of ABs. We can assume that these strain-by-strain concordance results are also true for bacteria in complex microbial samples, and conclude that AMRP obtained from metagenomic ARG analysis can help choose efficient ABs. This is illustrated using AMRP by a canine external otitis sample.https://peerj.com/articles/18802.pdfAntimicrobial resistanceGenomicsComplex microbial sampleClinical metagenomics
spellingShingle Norbert Solymosi
Adrienn Gréta Tóth
Sára Ágnes Nagy
István Csabai
Csongor Feczkó
Tamás Reibling
Tibor Németh
Clinical considerations on antimicrobial resistance potential of complex microbiological samples
PeerJ
Antimicrobial resistance
Genomics
Complex microbial sample
Clinical metagenomics
title Clinical considerations on antimicrobial resistance potential of complex microbiological samples
title_full Clinical considerations on antimicrobial resistance potential of complex microbiological samples
title_fullStr Clinical considerations on antimicrobial resistance potential of complex microbiological samples
title_full_unstemmed Clinical considerations on antimicrobial resistance potential of complex microbiological samples
title_short Clinical considerations on antimicrobial resistance potential of complex microbiological samples
title_sort clinical considerations on antimicrobial resistance potential of complex microbiological samples
topic Antimicrobial resistance
Genomics
Complex microbial sample
Clinical metagenomics
url https://peerj.com/articles/18802.pdf
work_keys_str_mv AT norbertsolymosi clinicalconsiderationsonantimicrobialresistancepotentialofcomplexmicrobiologicalsamples
AT adrienngretatoth clinicalconsiderationsonantimicrobialresistancepotentialofcomplexmicrobiologicalsamples
AT saraagnesnagy clinicalconsiderationsonantimicrobialresistancepotentialofcomplexmicrobiologicalsamples
AT istvancsabai clinicalconsiderationsonantimicrobialresistancepotentialofcomplexmicrobiologicalsamples
AT csongorfeczko clinicalconsiderationsonantimicrobialresistancepotentialofcomplexmicrobiologicalsamples
AT tamasreibling clinicalconsiderationsonantimicrobialresistancepotentialofcomplexmicrobiologicalsamples
AT tibornemeth clinicalconsiderationsonantimicrobialresistancepotentialofcomplexmicrobiologicalsamples